Back to Search
ASHLYN KAMIN, PH.D.
PH.D.
Other Specialist/Technologist
NPI: 1760332258Individual
Specialties, Licenses & Credentials
Other Specialist/TechnologistPrimary
Specialist/Technologist, Other
Code: 246Z00000X
Research & Publications (5)
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
PMID 17610993·J Am Acad Dermatol·2007
3-trial
[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
PMID 16033477·J Dtsch Dermatol Ges·2005
4-observational
Imiquimod in the treatment of extensive recurrent lentigo maligna.
PMID 15692515·J Am Acad Dermatol·2005
5-case
Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
PMID 15459547·Dermatology·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1715A N 45TH ST
SEATTLE, WA 98103 - Phone
- (419) 651-8959
Quick Facts
- NPI
- 1760332258
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile